FDA.reportPublic FDA data

Newpong

FDA Registration(s)#

Registration, FEI, Name table
RegistrationFEINameStatusInitial importerExpiration yearAddress
30447771173044777117NEWPONG CO.,LTD.1N2026-01-01#1212, #1216 SJ Technoville, 278, Beotkkot-ro, Geumcheon-gu Seoul KR 08511

GUDID Contact Samples#

Sampled from matched GUDID device records for this company; this is not an exhaustive company contact directory.

Source GUDID, Product, Phone table
Source GUDIDProductPhoneEmail
08800028800031LSSA (NP-200) - LSSA is intended for the fragmentation and emulsification of subcutaneous fatty tissues for aesthetic body contouring LSSA is indicated for use in the following surgical specialists when the fragmentation and aspiration of adipose tissue is desired: - Plastic and Reconstruction Surgery. - Orthopedic Surgery.786-815-9121latin@newpong.com

Registered Device Listings#

Registration key, Listing key, Premarket submission table
Registration keyListing keyPremarket submissionDeviceProduct codeDecision date
3499042059171705K252495LSSA (NP-200)QPB2026-04-03

Product Codes Associated With Registrations#

Product code, Registration listing records, Latest decision table
Product codeRegistration listing recordsLatest decision
QPB12026-04-03

GUDID#